United States Antidiabetic SGLT-2 Inhibitor Sales Market Report 2021

1 Antidiabetic SGLT-2 Inhibitor Overview

1.1 Product Overview and Scope of Antidiabetic SGLT-2 Inhibitor

1.2 Classification of Antidiabetic SGLT-2 Inhibitor

1.2.1 Type 1

1.2.2 Type 2

1.2.3 Type 3

1.3 Applications of Antidiabetic SGLT-2 Inhibitor

1.4 USA Market Size (Value and Volume) of Antidiabetic SGLT-2 Inhibitor (2011-2021)

1.4.1 USA Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)

1.4.2 USA Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)

1.4.3 USA Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)

2 USA Antidiabetic SGLT-2 Inhibitor Competition by Manufacturers

2.1 USA Antidiabetic SGLT-2 Inhibitor Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Antidiabetic SGLT-2 Inhibitor Revenue and Share by Manufactures (2015-2016)

3 USA Antidiabetic SGLT-2 Inhibitor (Volume and Value) by Type

3.1 USA Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Type (2011-2021)

3.2 USA Antidiabetic SGLT-2 Inhibitor Revenue and Market Share by Type (2011 and 2021)

4 USA Antidiabetic SGLT-2 Inhibitor (Volume) by Application

5 USA Antidiabetic SGLT-2 Inhibitor Manufacturers Analysis

5.1 Sanofi

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Antidiabetic SGLT-2 Inhibitor Product Type and Technology

5.1.2.1 Type 1

5.1.2.2 Type 2

5.1.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Sanofi (2015 and 2016)

5.2 Johnson & Johnson

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Medicine Product Type and Technology

5.2.2.1 Type 1

5.2.2.2 Type 2

5.2.3 Medicine Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

5.3 Bristol-Myers Squibb

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Bristol-Myers Squibb Product Type and Technology

5.3.2.1 Type 1

5.3.2.2 Type 2

5.3.3 Bristol-Myers Squibb Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)

5.4 AstraZeneca

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Eli Lilly Product Type and Technology

5.4.2.1 Type 1

5.4.2.2 Type 2

5.4.3 AstraZeneca Sales, Revenue, Price of AstraZeneca (2015 and 2016)

5.5 Boehringer Ingelheim

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Boehringer Ingelheim Product Type and Technology

5.5.2.1 Type 1

5.5.2.2 Type 2

5.5.3 Boehringer Ingelheim Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)

5.6 GlaxoSmithKline

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 GlaxoSmithKline Product Type and Technology

5.6.2.1 Type 1

5.6.2.2 Type 2

5.6.3 GlaxoSmithKline Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

5.7 Pfizer

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Pfizer Product Type and Technology

5.7.2.1 Type 1

5.7.2.2 Type 2

5.7.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)

5.8 Takeda Pharmaceuticals

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 Takeda Pharmaceuticals Product Type and Technology

5.8.2.1 Type 1

5.8.2.2 Type 2

5.8.3 Takeda Pharmaceuticals Sales, Revenue, Price of Takeda Pharmaceuticals (2015 and 2016)

5.9 Eli Lilly

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 Eli Lilly Product Type and Technology

5.9.2.1 Type 1

5.9.2.2 Type 2

5.9.3 Eli Lilly Sales, Revenue, Price of Eli Lilly (2015 and 2016)

5.10 Merck & Co.

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Merck & Co. Product Type and Technology

5.10.2.1 Type 1

5.10.2.2 Type 2

5.10.3 Merck & Co. Sales, Revenue, Price of Merck & Co. (2015 and 2016)

5.11 Novo Nordisk

6 Antidiabetic SGLT-2 Inhibitor Technology and Development Trend

6.1 Antidiabetic SGLT-2 Inhibitor Technology Analysis

6.2 Antidiabetic SGLT-2 Inhibitor Technology Development Trend

7 Research Findings and Conclusion

Figure Picture of Antidiabetic SGLT-2 Inhibitor

Table Classification of Antidiabetic SGLT-2 Inhibitor

Figure USA Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Types in 2015

Table Applications of Antidiabetic SGLT-2 Inhibitor

Figure USA Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Applications in 2015

Table USA Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)

Figure USA Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)

Figure USA Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)

Table USA AAA Sales of Key Manufacturers (2015 and 2016)

Table USA AAA Sales Share by Manufacturers (2015 and 2016)

Figure 2015 AAA Sales Share by Manufacturers

Figure 2016 AAA Sales Share by Manufacturers

Table USA AAA Revenue by Manufacturers (2015 and 2016)

Table USA AAA Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA AAA Revenue Share by Manufacturers

Table 2016 USA AAA Revenue Share by Manufacturers

Table USA AAA Sales and Market Share by Type (2011-2021)

Table USA AAA Sales Share by Type (2011-2021)

Figure Sales Market Share of AAA by Type (2011-2021)

Figure USA AAA Sales Growth Rate by Type (2011-2021)

Table USA AAA Revenue and Market Share by Type (2011-2021)

Table USA AAA Revenue Share by Type (2011-2021)

Figure Revenue Market Share of AAA by Type (2011-2021)

Figure USA AAA Revenue Growth Rate by Type (2011-2021)

Table USA AAA Sales and Market Share by Application (2011-2021)

Table USA AAA Sales Share by Application (2011-2021)

Figure Sales Market Share of AAA by Application (2011-2021)

Figure USA AAA Sales Growth Rate by Application (2011-2021)

Table Sanofi Basic Information List

Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Sanofi (2015 and 2016)

Table Johnson & Johnson Basic Information List

Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

Table Bristol-Myers Squibb Basic Information List

Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)

Table AstraZeneca Basic Information List

Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of AstraZeneca (2015 and 2016)

Table Boehringer Ingelheim Basic Information List

Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)

Table GlaxoSmithKline Basic Information List

Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

Table Pfizer Basic Information List

Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Pfizer (2015 and 2016)

Table Takeda Pharmaceuticals Basic Information List

Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Takeda Pharmaceuticals (2015 and 2016)

Table Eli Lilly Basic Information List

Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Eli Lilly (2015 and 2016)

Table Merck & Co. Basic Information List

Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Merck & Co. (2015 and 2016)

Table Novo Nordisk Basic Information List

Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Novo Nordisk (2015 and 2016)